World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

Tacconelli, Evelina;
2021-01-01

Abstract

World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).
2021
antiviral drugs, Covid-19
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1031314
Citazioni
  • ???jsp.display-item.citation.pmc??? 1174
  • Scopus 1547
  • ???jsp.display-item.citation.isi??? 1652
social impact